Herborium® Enters $220Billion Digital Content Market
Herborium Group, Inc. (HBRM) announces its transition to a “Content Plus Product” model starting Q4 2022. This strategic shift aims to capitalize on the growing online beauty market, which has seen a 21% growth since 2018. The new platform will offer personalized self-care regimens, integrating AI technology through a partnership with ADRECOM INC. The company seeks to provide solutions for unmet skin health needs while establishing a consortium for natural wellness products. This innovative approach aims to enhance market reach, consumer satisfaction, and shareholder value through diversified revenue streams.
- Transition to a 'Content Plus Product' model expected to enhance growth opportunities in the $230 billion digital content market.
- Partnership with ADRECOM INC. aims to leverage AI for innovative self-care solutions.
- Expansion of product offerings in the growing online beauty market, enhancing market reach and consumer satisfaction.
- None.
The First Stage of Transition Into the “Content Plus Product” Entity To Be Deployed in Fourth Quarter of 2022
Houston, May 10, 2022 (GLOBE NEWSWIRE) -- Houston, Texas, 05/10/2022. Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal, beauty and wellness products with a clinically validated records of efficacy and safety, announced today that it officially commenced its transition into “Content Plus Product Company” initially previewed in the Company’s February 28th Shareholders Update Letter
Covid Pandemic and following economic and social changes accelerated new healthcare, consumer and technology trends resulted in changing landscape of the e commerce. With
Simplifying buying on-line, curating purchasing decisions through personalizing regimens of natural self-care and beauty, individualizing diagnosis within healthcare, wellness and beauty concerns and curating unique integrated natural solutions easily accessible by consumers and service providers, positions the Company as a highly competitive and innovative part of the
To develop its innovative technology Herborium partnered with ADRECOM INC. a innovative, technology company focused on development and application of AI (Artificial Intelligence). Herborium Self-Care platform is to integrate not only Herborium products, expertise, and content but also those of qualified partners to provide the most comprehensive, multi-facet hosting and delivery digital tool in natural selfcare and beauty.
In addition, due to Herborium unique expertise, the new platform will provide forum for consumers and professionals seeking natural alternatives to serious self-care concerns (in the first stage focused on skin health) unanswered by traditional providers.
Finally- the innovative technology platform shall allow the Company to establish
a Consortium of selected natural products and know-how partners that together provide one of a kind, comprehensive, easy to use and friendly to access one stop shopping, treatments, counseling, advisement and curated consumer forum in the highly thought after natural wellness and beauty space.
From business perspective this New Model allows Herborium to realize multiple revenues streams, significantly expand its market reach, increase consumer satisfaction and loyalty, and create additional shareholders value trough revenues growth and potential for further partnerships and acquisitions.
The Platform and Consortium is expected to launch in a Fourth Quarter of 2022.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics company that develops, license and markets proprietary, botanical based medicinal and wellness products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, women’s health and selected sexual disorders and has built the versatile, technologically advanced, interactive content platform to support consumer needs. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr and www.acneasesp.com
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
Attachment
FAQ
What is the significance of Herborium Group's transition to a Content Plus Product model?
When is the launch date for Herborium Group's new platform?
How does Herborium Group plan to improve its market reach?
What growth opportunities does Herborium Group expect from this transition?
